As part of its goal to enhance access to quality healthcare throughout the Kingdom, AKDITAL has continued its expansion strategy during the first half of 2024. Three new healthcare facilities were inaugurated, increasing the Group’s total capacity to 2,698 beds. These new facilities include the Khouribga International Clinic, the Ibn Nafis International Hospital in Marrakech, and the Mogador International Clinic in Essaouira, which together add 383 beds to the existing capacity.
To align its practices with the highest quality standards, AKDITAL also made significant progress in the first half of 2024 in its Qmentum International accreditation cycle with the Accreditation Canada organization.
Progress in Activity Indicators
The Group’s revenue for the first half of 2024 amounts to MAD 1,249 million, reflecting robust growth of 51% compared to MAD 828 million for the first half of 2023. This positive performance is attributed to the consolidation of legacy entities and the success of the facilities opened in 2022 and 2023. Regarding its contribution to the Group’s total revenue, the oncology segment saw its share increase from 29% in the first half of 2023 to 32% in 2024. Strengthening of profitability and cost control
EBITDA for the first half of 2024 stands at MAD 334 million, representing a 56% increase. This achievement stems from the Group’s operational efficiency efforts through stringent expense management. As of June 30, 2024, consolidated net profit reached MAD 127 million, marking a 70% increase compared to MAD 75 million in the first half of 2023.
This progress is fueled by improvements in the Group’s operational performance. The Group’s share of net income (RNPG) amounts to MAD 113 million.
Perspectives
AKDITAL is pursuing its ambitious expansion program for 2024, with plans to open 12 new establishments, 3 of which are already operational. These developments will enable the Group to achieve a total capacity of over 3,700 beds across 33 facilities in 24 cities, a 61% increase compared to 2023. Building on the success of its capital increase in July 2024, AKDITAL aims to accelerate its expansion beyond this year by targeting regions with high demand for healthcare infrastructure to further support the generalization of Compulsory Health Insurance (AMO).
AKDITAL’s Healthcare Expansion and Financial Growth in 2024
As part of its objective to strengthen access to quality care across the Kingdom, AKDITAL continued its expansion strategy during the first half of 2024. Three new health establishments were inaugurated, bringing the total capacity of the Group to 2,698 beds. These new infrastructures include the Khouribga International Clinic, the Ibn Nafis International Hospital in Marrakech, and the Mogador International Clinic in Essaouira, which together add 383 beds to the existing capacity.
With the aim of aligning its practices with the highest quality standards, AKDITAL also made significant progress during H1 2024 in its Qmentum International accreditation cycle with the Accreditation Canada organization.
Progress in Activity Indicators
The Group’s turnover for the first half of 2024 amounts to MAD 1,249 million, recording strong growth of 51% compared to MAD 828 million for H1 2023. This robust performance reflects both the consolidation of historic entities and the success of the establishments opened in 2022 and 2023. In terms of contribution to the Group’s overall turnover, the oncology activity saw its share increase from 29% in H1 2023 to 32% in H1 2024.
Strengthening Profitability and Cost Control
EBITDA for the first half of 2024 stands at MAD 334 million, up 56%. This performance is the result of the Group’s operational efficiency efforts, through rigorous expense management. As of June 30, 2024, the consolidated net profit amounted to MAD 127 million, recording an increase of 70% compared to MAD 75 million in H1 2023.
This progress is driven by the improvement in the Group’s operational performance. The group’s share of net income (RNPG) stands at MAD 113 million.
Perspectives on Future Growth
Akdital is continuing its ambitious expansion program for 2024, with 12 new establishment openings planned, 3 of which are already operational. These developments will allow the Group to reach a total capacity of over 3,700 beds spread across 33 establishments in 24 cities, marking an increase of 61% compared to 2023.
Building on the success of its capital increase in July 2024, AKDITAL intends to accelerate its expansion beyond this year by targeting regions with high demand for health infrastructure, in support of the generalization of Compulsory Health Insurance (AMO).
Benefits of AKDITAL’s Strategy
- Increased Accessibility: With more healthcare facilities, patients in various regions can access essential medical services.
- Improved Quality: Commitment to international accreditation ensures that all facilities meet high standards of care.
- Economic Growth: Job creation within the healthcare sector supports local economies.
- Enhanced Services: Expansion can lead to the introduction of specialized services, like oncology, which is seeing increased demand.
Financial Performance Overview
| Indicator | H1 2023 | H1 2024 | Growth (%) |
|---|---|---|---|
| Turnover (MAD) | 828 million | 1,249 million | 51% |
| EBITDA (MAD) | 214 million | 334 million | 56% |
| Net Profit (MAD) | 75 million | 127 million | 70% |
| Oncology Contribution (%) | 29% | 32% | Increase |
Case Studies: Successful AKDITAL Facilities
Khouribga International Clinic
Inaugurated in early 2024, this clinic has rapidly become a pillar of healthcare in the Khouribga region, providing comprehensive health services to thousands of patients.
Ibn Nafis International Hospital
This state-of-the-art facility in Marrakech not only enhances service delivery in the region but also serves as a training ground for medical professionals.
Mogador International Clinic
Located in Essaouira, this clinic focuses on preventative care, significantly reducing hospital admissions and improving the community’s overall health.
First-Hand Experience from Patients
Patients who have accessed services at the newly inaugurated facilities have reported a marked improvement in the quality of care received, often highlighting the well-trained staff and advanced medical technology as key contributing factors to their positive health outcomes.
As AKDITAL continues its path of growth and excellence, the future of healthcare in Morocco looks promising with extensive infrastructure, quality assurance, and community support post-accreditation.
